Medidata is a Dassault Systèmes company and a global leader that support the entire clinical trial process by creating end-to-end solutions. They officially announced that SHYFT Analytics will be adopting the Acorn AI, by Medidata brand.
SHYFT customers valued innovative commercial and data analytics technologies and services. It will be operating as the Commercial Data Solutions (CDS) team at Acorn AI. Medidata acquired SHYFT Analytics in 2018. Over the last 20 years, Acorn AI by Medidata was built on data, AI technologies, and domain expertise. It helped life sciences companies answer the questions that matter.
Current solutions provided by Acorn AI
- Provide real-time operational insights which improve study success using intelligent trials
- A randomized control is not feasible for diseases but Synthetic Control Arms can be used to control
- To improve the overall probability of success, Trial Design helps to bring together insights from historic clinical trials and contemporaneous real-world
- Therapies accelerate launch and peak patient adoption are possible with Commercial Data Solutions
As per Sastry Chilukuri, president, Acorn AI by Medidata, under a unified Acorn AI brand provides combined capabilities to customers. More precise drugs are created as scientific breakthroughs continue which target specific patient characteristics. R&D and Commercial are connected in new ways which are changing the commercialization paradigm. Acorn AI provides the industry with a platform to combine Clinical and Real-world insights that provide capabilities and help customers accelerate their therapies to patients.
Bruno Lempernesse leads Acorn AI’s Commercial Data Solutions team and he was previously CEO of Inflexxion. Inflexxion is a technology software SaaS solutions company. It contains clinical assessment tools, predictive analytics, and Real World Clinical Data. These are used by pharmaceutical companies, healthcare organizations, providers, and regulatory authorities in the space of substance use disorders, like opioid addiction.
Medidata is a wholly-owned subsidiary of Dassault Systèmes. In the age of personalized medicine, a 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences. The first end-to-end scientific and business platform is provided from research to commercialization.
Medidata creates hope for millions of patients and is leading the digital transformation of life sciences. Medidata helps pharmaceutical, biotech, medical device, and diagnostics companies, and academic researchers by providing evidence and insights to accelerate value, minimize risk, and optimize outcomes. It is the world’s most-used platform for clinical development, commercial, and real-world data accessed by more than one million registered users across 1,500 customers and partners.
Medidata, a Dassault Systèmes company, and it is headquartered in New York City. It has offices around the world to meet the needs of its customers. Acorn AI, by Medidata, a Dassault Systèmes company helps life sciences companies deliver actionable insights by combining data, technology, and deep expertise across the entire continuum of clinical development.
